Intrexon | XON - Ebit





Ebit Perubahan Tanggal
Agenus USD 15.05M 656K 2026-03
Alaunos Therapeutics USD -952K 60K 2026-06
Amgen USD 4.68B 65M 2026-09
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Incyte USD -707.47M 1.41B 2026-09
Intrexon USD -26.3M 2.91M 2024-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
MacroGenics USD -65.25M 33.36M 2026-06
MannKind USD -59.44M 8.79M 2026-09
Merck USD 7.33B 6.49B 2026-09
Novartis USD 5.14B 411M 2026-09
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 11.46B 1.91B 2026-06
Thermo Fisher Scientific USD 2.46B 277M 2026-09
Veracyte USD 18.02M 5.94M 2026-09
Xencor USD -36.6M 41.26M 2026-06